$PBSV Market Cap: $13.77 Million
Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue
$7.267M
TTM
Gross Margin
27.79%
TTM
Net Earnings
-$514.5K
TTM
Current Assets
$15.53M
Q1 2025
Current Liabilities
$3.420M
Q1 2025
Current Ratio
454.17%
Q1 2025
Total Assets
$16.08M
Q1 2025
Total Liabilities
$4.081M
Q1 2025
Book Value
$12.00M
Q1 2025
Cash
$7.307M
Q1 2025
P/E
-26.77
Nov 29, 2024 EST
Free Cash Flow
-$1.802M
TTM

Revenues

Revenues

Revenue YoY Change

Revenues

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
Revenue $9.509M $16.98M $19.40M $20.12M $21.56M $19.51M $17.80M $13.30M $19.54M $23.38M $27.56M $33.06M $29.23M $19.93M $11.35M $11.48M $15.20M $16.21M $14.23M $10.00K
YoY Change -43.99% -12.48% -3.56% -6.72% 10.55% 9.61% 33.84% -31.94% -16.46% -15.15% -16.64% 13.1% 46.66% 75.59% -1.13% -24.47% -6.23% 13.91% 142200.0%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
Revenue $9.509M $16.98M $19.40M $20.12M $21.56M $19.51M $17.80M $13.30M $19.54M $23.38M $27.56M $33.06M $29.23M $19.93M $11.35M $11.48M $15.20M $16.21M $14.23M $10.00K
Cost Of Revenue $6.993M $11.91M $14.52M $14.76M $14.90M $13.33M $12.11M $9.455M $13.75M $15.90M $18.58M $21.23M $19.36M $13.07M $7.950M $7.640M $9.410M $9.380M $8.120M
Gross Profit $2.516M $5.066M $4.881M $5.360M $6.667M $6.177M $5.687M $3.842M $5.783M $7.484M $8.970M $11.83M $9.870M $6.860M $3.390M $3.840M $5.790M $6.820M $6.110M
Gross Profit Margin 26.46% 29.84% 25.16% 26.65% 30.92% 31.66% 31.95% 28.89% 29.6% 32.01% 32.55% 35.78% 33.77% 34.42% 29.87% 33.45% 38.09% 42.07% 42.94%

Selling, General & Admin Expense

Research & Development

No data

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

No data

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
Selling, General & Admin $3.804M $3.949M $3.707M $9.214M $4.441M $4.480M $4.599M $4.660M $5.875M $5.703M $6.110M $5.760M $4.140M $3.410M $2.780M $2.920M $3.140M $3.180M $2.030M $40.00K
YoY Change -3.68% 6.54% -59.77% 107.46% -0.87% -2.58% -1.32% -20.68% 3.01% -6.66% 6.08% 39.13% 21.41% 22.66% -4.79% -7.01% -1.26% 56.65% 4975.0%
% of Gross Profit 151.18% 77.94% 75.93% 171.9% 66.62% 72.53% 80.86% 121.28% 101.59% 76.2% 68.12% 48.69% 41.95% 49.71% 82.01% 76.04% 54.23% 46.63% 33.22%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $48.09K $51.11K $72.73K $86.28K $99.10K $74.60K $107.7K $312.6K $357.5K $380.0K $340.0K $320.0K $320.0K $320.0K $310.0K $230.0K $210.0K $200.0K
YoY Change -5.9% -29.73% -15.71% -12.93% 32.84% -30.72% -65.55% -12.56% -5.93% 11.76% 6.25% 0.0% 0.0% 3.23% 34.78% 9.52% 5.0%
% of Gross Profit 0.95% 1.05% 1.36% 1.29% 1.6% 1.31% 2.8% 5.4% 4.78% 4.24% 2.87% 3.24% 4.66% 9.44% 8.07% 3.97% 3.08% 3.27%
Operating Expenses $3.804M $3.949M $3.707M $9.214M $4.441M $4.480M $4.599M $4.660M $5.875M $5.703M $6.110M $5.760M $4.130M $3.410M $2.790M $2.920M $3.130M $3.180M $2.230M $40.00K
YoY Change -3.68% 6.54% -59.77% 107.46% -0.87% -2.58% -1.32% -20.68% 3.01% -6.66% 6.08% 39.47% 21.11% 22.22% -4.45% -6.71% -1.57% 42.6% 5475.0%
Operating Profit -$1.288M $1.117M $1.175M -$3.854M $2.226M $1.697M $1.088M -$817.7K -$91.75K $1.781M $2.860M $6.070M $5.740M $3.450M $600.0K $920.0K $2.660M $3.640M $3.880M
YoY Change -215.23% -4.9% -130.49% -273.16% 31.17% 55.91% -233.09% 791.23% -105.15% -37.72% -52.88% 5.75% 66.38% 475.0% -34.78% -65.41% -26.92% -6.19%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
Interest Expense $64.15K $0.00 $11.47K $0.00 $0.00 $0.00 $10.00K $10.00K -$30.00K -$140.0K -$280.0K -$390.0K
YoY Change -100.0% 0.0% -133.33% -78.57% -50.0% -28.21%
% of Operating Profit 5.46% 0.64% 0.0% 0.0% 0.0% 0.29% 1.67% -3.26% -5.26% -7.69% -10.05%
Other Income/Expense, Net $532.1K $570.1K $13.42K $1.978M $64.46K $526.6K $435.5K $43.75K -$56.98K
YoY Change -6.65% 4148.59% -99.32% 2967.96% -87.76% 20.9% 895.5% -176.78%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

No data

Net Income To Revenue Ratio

Pretax & Net Income

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
Pretax Income -$755.4K $1.687M $1.188M -$1.876M $2.290M $2.223M $1.524M -$774.0K -$203.7K $1.793M $2.880M $6.080M $5.760M $3.460M $620.0K $900.0K $2.510M $3.340M $3.500M -$20.00K
YoY Change -144.77% 42.0% -163.35% -181.92% 3.0% 45.9% -296.88% 279.87% -111.36% -37.75% -52.63% 5.56% 66.47% 458.06% -31.11% -64.14% -24.85% -4.57% -17600.0%
Income Tax $22.17K $377.3K $181.7K $213.2K $239.1K $136.0K $85.53K $3.870K $52.83K $168.0K $460.0K $1.170M $1.070M $300.0K $250.0K $360.0K $1.020M $1.440M $1.160M $0.00
% Of Pretax Income 22.36% 15.29% 10.44% 6.12% 5.61% 9.37% 15.97% 19.24% 18.58% 8.67% 40.32% 40.0% 40.64% 43.11% 33.14%
Net Earnings -$777.6K $1.310M $1.007M -$2.089M $2.051M $2.087M $1.280M -$1.415M -$256.6K $1.625M $2.410M $4.910M $4.690M $3.160M $370.0K $540.0K $1.490M $1.900M $2.340M -$20.00K
YoY Change -159.35% 30.15% -148.18% -201.87% -1.74% 63.1% -190.45% 451.45% -115.79% -32.58% -50.92% 4.69% 48.42% 754.05% -31.48% -63.76% -21.58% -18.8% -11800.0%
Net Earnings / Revenue -8.18% 7.72% 5.19% -10.39% 9.51% 10.7% 7.19% -10.64% -1.31% 6.95% 8.74% 14.85% 16.05% 15.86% 3.26% 4.7% 9.8% 11.72% 16.44% -200.0%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.03 $0.06 $0.04 -$90.73K $89.02K $90.30K $55.41K -$61.25K -$11.15K $69.44K $101.7K $207.5K $204.4K $140.1K $16.53K $24.18K $66.94K $85.70K $130.9K -$74.07K

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

No data

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

No data

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
Cash & Short-Term Investments $14.98M $14.46M $17.47M $17.14M $15.49M $16.07M $11.62M $13.79M $14.93M $15.16M $12.12M $6.630M $4.410M $2.410M $2.050M $3.090M $4.790M $2.280M $50.00K
YoY Change 3.56% -17.21% 1.93% 10.64% -3.63% 38.36% -15.77% -7.59% -1.54% 25.08% 82.81% 50.34% 82.99% 17.56% -33.66% -35.49% 110.09% 4460.0%
Cash & Equivalents $10.45M $14.46M $17.47M $17.14M $15.49M $16.03M $11.59M $13.77M $14.89M $15.09M $12.05M $6.540M $4.320M $2.320M $2.050M $3.090M $4.790M $2.280M
Short-Term Investments $4.531M $0.00 $44.48K $26.60K $20.28K $33.43K $70.00K $70.00K $100.0K $100.0K $100.0K
Other Short-Term Assets $483.0K $498.4K $740.9K $468.7K $453.8K $394.0K $3.741M $981.1K $891.9K $780.0K $770.0K $380.0K $330.0K $270.0K $300.0K $190.0K $280.0K $470.0K
YoY Change -3.08% -32.73% 58.07% 3.29% 15.17% -89.47% 281.3% 10.0% 14.35% 1.3% 102.63% 15.15% 22.22% -10.0% 57.89% -32.14% -40.43%
Inventory
Prepaid Expenses
Receivables $3.941M $4.983M $4.613M $9.728M $8.781M $5.193M $6.317M $6.853M $7.448M $6.390M $7.400M $7.580M $4.860M $2.520M $2.040M $3.250M $3.560M $5.800M $0.00
Other Receivables $0.00 $0.00 $0.00 $1.250M $1.250M $1.750M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $19.40M $19.94M $22.82M $28.58M $25.97M $23.41M $21.68M $21.63M $23.27M $22.32M $20.29M $14.60M $9.610M $5.200M $4.390M $6.530M $8.630M $8.540M $50.00K
YoY Change -2.72% -12.61% -20.16% 10.05% 10.95% 8.01% 0.22% -7.04% 4.24% 10.0% 38.97% 51.93% 84.81% 18.45% -32.77% -24.33% 1.05% 16980.0%
Property, Plant & Equipment $389.3K $576.4K $745.5K $1.064M $290.7K $298.0K $250.6K $2.334M $854.0K $870.0K $980.0K $1.110M $1.220M $1.320M $1.570M $1.520M $800.0K $400.0K
YoY Change -32.46% -22.69% -29.95% 266.16% -2.47% 18.92% -89.26% 173.32% -1.84% -11.22% -11.71% -9.02% -7.58% -15.92% 3.29% 90.0% 100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $111.7K $130.9K $353.4K $270.2K $367.4K $418.5K $422.9K $35.58K $18.26K $20.00K $20.00K $30.00K $30.00K $10.00K $10.00K $10.00K $20.00K $10.00K
YoY Change -14.67% -62.96% 30.75% -26.45% -12.2% -1.05% 1088.67% 94.85% -8.7% 0.0% -33.33% 0.0% 200.0% 0.0% 0.0% -50.0% 100.0%
Total Long-Term Assets $501.0K $707.3K $1.099M $1.335M $658.1K $1.967M $673.5K $2.370M $872.2K $890.0K $990.0K $1.140M $1.240M $1.360M $1.630M $1.580M $930.0K $600.0K $0.00
YoY Change -29.17% -35.64% -17.66% 102.79% -66.53% 191.97% -71.58% 171.68% -2.0% -10.1% -13.16% -8.06% -8.82% -16.56% 3.16% 69.89% 55.0%
Total Assets $19.90M $20.65M $23.92M $29.92M $26.63M $25.38M $22.35M $24.00M $24.14M $23.21M $21.28M $15.74M $10.85M $6.560M $6.020M $8.110M $9.560M $9.140M $50.00K
YoY Change
Accounts Payable $1.467M $1.630M $2.071M $1.938M $1.590M $2.140M $1.417M $2.091M $2.062M $2.360M $2.830M $2.560M $1.940M $1.210M $0.00 $2.710M $2.710M $2.710M
YoY Change -9.95% -21.32% 6.86% 21.89% -25.69% 51.06% -32.24% 1.4% -12.63% -16.61% 10.55% 31.96% 60.33% -100.0% 0.0% 0.0%
Accrued Expenses $152.5K $140.9K $130.1K $162.9K $0.00
YoY Change 8.24% 8.3% -20.17%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $1.299M $11.03K $13.77K $13.95K $22.95K $22.78K $20.00K $30.00K $40.00K $30.00K $20.00K $40.00K $50.00K $40.00K $40.00K
YoY Change -100.0% 11680.96% -19.9% -1.29% -39.22% 0.75% 13.9% -33.33% -25.0% 33.33% 50.0% -50.0% -20.0% 25.0% 0.0%
Total Short-Term Liabilities $2.154M $2.108M $2.651M $3.793M $3.671M $2.566M $1.543M $2.159M $2.124M $2.630M $3.180M $2.780M $2.520M $1.430M $1.300M $3.990M $4.770M $3.950M $0.00
YoY Change 2.18% -20.5% -30.1% 3.33% 43.06% 66.29% -28.52% 1.63% -19.25% -17.3% 14.39% 10.32% 76.22% 10.0% -67.42% -16.35% 20.76%
Long-Term Debt $0.00 $0.00 $0.00 $699.3K $67.08K $46.03K $59.80K $29.00K $51.95K $70.00K $50.00K $80.00K $90.00K $50.00K $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -100.0% 942.55% 45.73% -23.03% 106.21% -44.18% -25.79% 40.0% -37.5% -11.11% 80.0%
Other Long-Term Liabilities $194.0K $346.5K $505.3K $647.9K $17.95K $17.95K $0.00 $60.00K $70.00K $2.630M $5.040M
YoY Change -44.0% -31.43% -22.01% 3509.64% 0.0% -14.29% -97.34% -47.82%
Total Long-Term Liabilities $194.0K $346.5K $505.3K $1.347M $85.03K $63.98K $59.80K $29.00K $51.95K $70.00K $50.00K $80.00K $90.00K $50.00K $60.00K $70.00K $2.630M $5.040M $0.00
YoY Change -44.0% -31.43% -62.49% 1484.46% 32.9% 6.99% 106.21% -44.18% -25.79% 40.0% -37.5% -11.11% 80.0% -16.67% -14.29% -97.34% -47.82%
Total Liabilities $3.775M $4.093M $5.007M $7.202M $6.026M $5.115M $1.603M $2.188M $2.176M $2.700M $3.230M $2.860M $2.620M $1.490M $1.360M $4.060M $7.400M $8.990M $0.00
YoY Change -7.77% -18.25% -30.48% 19.53% 17.81% 219.12% -26.73% 0.54% -19.41% -16.41% 12.94% 9.16% 75.84% 9.56% -66.5% -45.14% -17.69%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

No data

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
Basic Shares Outstanding 22.97M shares 22.97M shares 23.00M shares 23.03M shares 23.00M shares
Diluted Shares Outstanding 22.97M shares 23.00M shares 23.03M shares 23.16M shares 23.04M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Dividends

Stock Price

Market Cap: $13.775 Million

About Pharma-Bio Serv, Inc.

Pharma-Bio Serv, Inc. engages in the provision of technical compliance consulting service and microbiological and chemical laboratory testing services to the pharmaceutical, chemical, medical device, and biotechnology industries. The firm operates through four segments: Puerto Rico technical compliance consulting, United States technical compliance consulting, Europe technical compliance consulting, and Puerto Rico microbiological and chemical laboratory testing division (Lab). The firm provides a range of compliance-related consulting services. The firm provides microbiological testing services and chemical testing services through its laboratory testing facility in Puerto Rico. The firm's technical consulting services include regulatory compliance, validation, technology transfer, engineering, project management and process support. The firm markets its services to pharmaceutical, chemical, biotechnology, medical devices, cosmetic and food industries, and allied products companies in Puerto Rico, the United States, Europe and Brazil.

Industry: Services-Management Consulting Services Peers: